Dianthus Therapeutics | MGTA - بدهی های جاری

قیمت سهام
89.78
تغییر روزانه
-1.88 -2.05%
ماهیانه
4.59%
سالیانه
409.82%
Q2 پیش بینی
83.41




بدهی های جاری تغییر دادن تاریخ
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
Avita Medical AUD 62.68M 77K 2025-12
Celltrion KRW 4.01T 343.96B 2025-09
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
IQVIA Holdings USD 8.34B 170M 2025-12
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 1.99B 306M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Organon & Co USD 2.68B 117M 2025-09
Ovoca Bio EUR 186K 2.26M 2025-06
Pharma Mar EUR 93.88M 4.94M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Sartorius EUR 1.81B 254.3M 2025-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tectonic Therapeutic USD 9.67M 293K 2025-12
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 7.09B 269.8M 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09